{"id":"NCT01050816","sponsor":"Sewon Cellontech Co., Ltd.","briefTitle":"Effects of CHONDRON (Autologous Chondrocytes) With Ankle Cartilage Defect","officialTitle":"An Investigator Clinical Trial to Observe Effects of CHONDRON (Autologous Chondrocytes) for 12 Months in Patients With Ankle Cartilage Defect","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2009-01","completion":"2009-02","firstPosted":"2010-01-15","resultsPosted":"2010-05-07","lastUpdate":"2010-05-11"},"enrollment":30,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Articular Cartilage Defects of Ankle Joint"],"interventions":[{"type":"PROCEDURE","name":"Chondron(autologous chondrocyte) Implantation","otherNames":["Chondron"]}],"arms":[{"label":"Chondron implantation","type":"EXPERIMENTAL"}],"summary":"An open clinical trial transplanting CHONDRON (autologous chondrocytes) to ankle cartilage defect patients who are appropriate for the trial, and evaluating the validity and safety for 12 months.","primaryOutcome":{"measure":"Average Change From Baseline in American Orthopedic Foot and Ankle Society(AOFAS) at 12 Months Post-surgery","timeFrame":"baseline(preoperative stage),12months post-surgery","effectByArm":[{"arm":"Chondron Implantation","deltaMin":16.93,"sd":13.04}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":30},"commonTop":["pain","nausea","headache","epigastric soreness'","dyspepsia"]}}